• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

转移性胰腺癌:生活质量与生命长度的两难抉择。

Metastatic pancreatic cancer: the dilemma of quality vs. quantity of life.

作者信息

Shahrokni Armin, Saif Muhammad Wasif

机构信息

University of California. Los Angeles, CA, USA.

出版信息

JOP. 2013 Jul 10;14(4):391-4. doi: 10.6092/1590-8577/1663.

DOI:10.6092/1590-8577/1663
PMID:23846935
Abstract

Due to pancreatic cancer's dismal prognosis, much of management is focused upon palliation and symptom management, and the decision to treat a patient with more aggressive maneuvers must always take into account the impact upon a patient's quality of life. In addition, majority of the patients with advanced pancreatic cancer are elderly. Oncologists are challenged to make tough treatment decisions. Many elderly patients cannot tolerate side effects of chemotherapy, especially the combination regimens. Despite that many patients continue to receive chemotherapy even in the last month of their lives. The effect of referral to palliative care on health-related outcome especially for patients with poor quality of life is still not very clear. The authors will review abstracts that have focused on these fields that were presented at the Annual Meeting of ASCO 2013 (Abstracts #4009, #4053, #6607, #9518, #9538, #9539, #9546, and #9638).

摘要

由于胰腺癌预后不佳,其治疗大多聚焦于缓解症状和对症处理,决定对患者采取更积极的治疗措施时必须始终考虑对患者生活质量的影响。此外,大多数晚期胰腺癌患者为老年人。肿瘤学家面临着做出艰难治疗决策的挑战。许多老年患者无法耐受化疗的副作用,尤其是联合治疗方案。尽管如此,许多患者甚至在生命的最后一个月仍继续接受化疗。转诊至姑息治疗对健康相关结局的影响,尤其是对生活质量较差的患者,目前仍不太明确。作者将回顾在2013年美国临床肿瘤学会年会上发表的聚焦于这些领域的摘要(摘要编号#4009、#4053、#6607、#9518、#9538、#9539、#9546和#9638)。

相似文献

1
Metastatic pancreatic cancer: the dilemma of quality vs. quantity of life.转移性胰腺癌:生活质量与生命长度的两难抉择。
JOP. 2013 Jul 10;14(4):391-4. doi: 10.6092/1590-8577/1663.
2
Palliative care from the beginning of treatment for advanced pancreatic cancer. Highlights from the "2010 ASCO Gastrointestinal Cancers Symposium". Orlando, FL, USA. January 22-24, 2010.晚期胰腺癌治疗伊始的姑息治疗。“2010年美国临床肿瘤学会胃肠癌研讨会”要点。美国佛罗里达州奥兰多。2010年1月22日至24日。
JOP. 2010 Mar 5;11(2):154-7.
3
Chemotherapy and other supportive modalities in the palliative setting for pancreatic cancer.胰腺癌姑息治疗中的化疗和其他支持性治疗方法。
Cancer J. 2012 Nov-Dec;18(6):633-41. doi: 10.1097/PPO.0b013e318275896f.
4
Palliative care of pancreatic cancer. Highlights from the "2011 ASCO Annual Meeting". Chicago, IL, USA; June 3-7, 2011.胰腺癌的姑息治疗。“2011年美国临床肿瘤学会年会”亮点。美国伊利诺伊州芝加哥;2011年6月3日至7日。
JOP. 2011 Jul 8;12(4):355-7.
5
Locally advanced pancreatic cancer: current therapeutic approach.局部进展期胰腺癌:当前的治疗方法。
Oncologist. 2006 Jun;11(6):612-23. doi: 10.1634/theoncologist.11-6-612.
6
Any second-line therapy for advanced pancreatic cancer? Highlights from the "2010 ASCO Gastrointestinal Cancers Symposium". Orlando, FL, USA. January 22-24, 2010.晚期胰腺癌的二线治疗方案有哪些?2010年美国临床肿瘤学会(ASCO)胃肠道癌症研讨会亮点。美国佛罗里达州奥兰多。2010年1月22日至24日。
JOP. 2010 Mar 5;11(2):151-3.
7
Quality of life in patients with pancreatic cancer.胰腺癌患者的生活质量
JOP. 2012 Mar 10;13(2):182-4.
8
Palliative chemotherapy in elderly patients with common metastatic malignancies: A Hellenic Cooperative Oncology Group registry analysis of management, outcome and clinical benefit predictors.老年常见转移性恶性肿瘤患者的姑息化疗:希腊合作肿瘤学组关于管理、结局及临床获益预测因素的登记分析
Crit Rev Oncol Hematol. 2008 Jun;66(3):237-47. doi: 10.1016/j.critrevonc.2007.12.003. Epub 2008 Feb 1.
9
Trends in treatment for pancreatic cancer.胰腺癌的治疗趋势。
J Hepatobiliary Pancreat Surg. 2001;8(6):544-8. doi: 10.1007/s005340100023.
10
[Possible approaches to cancer chemotherapy in palliative care medicine].[姑息治疗医学中癌症化疗的可能方法]
Gan To Kagaku Ryoho. 2005 Feb;32(2):156-60.

引用本文的文献

1
EphA2‑enriched exosomes promote cell migration and are a potential diagnostic serum marker in pancreatic cancer.EphA2 富集的外泌体促进细胞迁移,是胰腺癌潜在的诊断血清标志物。
Mol Med Rep. 2020 Oct;22(4):2941-2947. doi: 10.3892/mmr.2020.11384. Epub 2020 Jul 28.
2
Centrosomal protein 55 activates NF-κB signalling and promotes pancreatic cancer cells aggressiveness.中心体蛋白 55 激活 NF-κB 信号通路并促进胰腺癌细胞的侵袭性。
Sci Rep. 2017 Jul 19;7(1):5925. doi: 10.1038/s41598-017-06132-z.
3
High Rab11-FIP4 expression predicts poor prognosis and exhibits tumor promotion in pancreatic cancer.
Rab11-FIP4高表达预示着胰腺癌预后不良,并具有肿瘤促进作用。
Int J Oncol. 2017 Feb;50(2):396-404. doi: 10.3892/ijo.2016.3828. Epub 2016 Dec 30.
4
Use of a novel herbal medicine in a 75-year-old woman with multi-metastatic pancreatic cancer: A case report and review of the literature.一种新型草药药物在一名75岁多转移性胰腺癌女性患者中的应用:病例报告及文献综述
Oncol Lett. 2015 Jul;10(1):263-267. doi: 10.3892/ol.2015.3237. Epub 2015 May 20.
5
Reduction of miR-29c enhances pancreatic cancer cell migration and stem cell-like phenotype.miR-29c水平降低会增强胰腺癌细胞的迁移能力和干细胞样表型。
Oncotarget. 2015 Feb 20;6(5):2767-78. doi: 10.18632/oncotarget.3089.